Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Marketers face rising pressure from tariffs, triopoly dominance: Growth is coming from mid-tier platforms and smarter strategies, EMARKETER analysts say at Possible conference.

ChatGPT's shopping tool threatens retail media revenues: Its product search could siphon ad dollars from retailers struggling with tariffs, higher prices, and weak demand.

TikTok makes a bid to encourage creators, agencies to livestream: The push is part of the platform’s strategic effort to avoid a US ban.

Minimalist trucks, maximalist ambitions: EV makers Slate and TELO are betting that simple, compact, and affordable EVs will resonate with buyers who are tired of bloated features and high price tags.

Nobody knows what’s ahead: Macroeconomic turmoil and shifting tariff policies make forecasting a guessing game that many consumer brands are opting out of.

Google aims to reset its ecosystem with AI-infused Pixel updates and expansion beyond phones—countering fragmentation and pressure from rivals.

Vaccine integrity project launched to counter medical misinformation: Vaccine makers have the tough job of currying favor with Trump’s health administration, while preserving the public’s trust in their medicines.

Novo Nordisk and Hims go from competitors to partners: The deal signals Novo’s desire to capture patients transitioning off compounded GLP-1s. All eyes turn to Eli Lilly, which at last check said it’s not affiliating with Hims.

Congress wants to end the pharma industry’s advertising expense write-offs: This has been proposed before, but under the new Trump administration’s anti-drug advertising stance, the bill could gain more traction and inspire other new rules.

Spotify showed resilience with strong Q1 gains: Still, margin pressures and licensing costs could challenge momentum ahead.

Spotify is scaling video podcast monetization fast: A YouTube-style model and creator tools are fueling the shift.

Social sharing aims to boost usage, yet without real-time info or buzz, it may struggle to stick

Pitching itself as a collaborator, Substack empowers major outlets like The New Republic and smaller creators to expand their reach.

Consumers are willing to spend on travel—under the right circumstances: Cruises, premium travel, and concert tourism are all seeing healthy demand despite industry headwinds.

81% of Gen Z and millennial consumers have switched brands in the past year, according to December 2024 data from Salesforce.